Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=45 Treatment

Mindfulness Intervention for Post-Covid Symptoms

COVID-19 · Post Acute Sequelae of SARS-CoV-2

Bottom Line

View on ClinicalTrials.gov: NCT05199233 ↗
Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Change in Stress — -5.0 units on a scale — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Muse S™ Headband system (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Mayo Clinic
Primary completion
Nov 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Stress		 -5.0 <0.001 sig
PRIMARY
Change in Anxiety		 -4.5 <0.001 sig

Summary

The purpose of this study is to assess the feasibility of using a wearable brain-sensing wellness device (Muse-S) to potentially reduce stress and anxiety during Post-Covid, which is characterized by increased stress and anxiety.

Eligibility Criteria

Inclusion Criteria

  • Identified with one of 3 Post-Covid Syndrome (PASC) phenotypes at Mayo Clinic Rochester.
  • Not pregnant by subject self-report at time of consent.
  • Have the ability to provide informed consent.
  • Have the ability to complete all aspects of this trial.
  • Have access to an iPhone, iPad, or Android device.
  • Have no contraindicating comorbid health condition which would interfere with the proper use of the Muse-SÔ system, as determined by the clinical investigators.

Exclusion Criteria

  • Used an investigational drug within the past 30 days.
  • Anyone that is not on a stable dose of medication for anxiety, depression or sleep.
  • Currently (within the past 3 weeks) been practicing mindfulness training on a weekly/regular basis.
  • Currently (within 3 weeks) has been enrolled in another clinical or research program which intervenes on the patients' QOL, or stress.
  • An unstable medical or mental health condition as determined by the physician investigator.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05199233). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search